JP2009540314A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540314A5
JP2009540314A5 JP2009514827A JP2009514827A JP2009540314A5 JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5 JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5
Authority
JP
Japan
Prior art keywords
statin
standard
lipid
marker
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009514827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2007/050344 external-priority patent/WO2007144467A1/en
Publication of JP2009540314A publication Critical patent/JP2009540314A/ja
Publication of JP2009540314A5 publication Critical patent/JP2009540314A5/ja
Pending legal-status Critical Current

Links

JP2009514827A 2006-06-12 2007-06-12 筋障害診断方法 Pending JP2009540314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81260206P 2006-06-12 2006-06-12
US87249506P 2006-12-04 2006-12-04
PCT/FI2007/050344 WO2007144467A1 (en) 2006-06-12 2007-06-12 Diagnostic method for myopathy

Publications (2)

Publication Number Publication Date
JP2009540314A JP2009540314A (ja) 2009-11-19
JP2009540314A5 true JP2009540314A5 (cg-RX-API-DMAC7.html) 2010-07-29

Family

ID=38831439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514827A Pending JP2009540314A (ja) 2006-06-12 2007-06-12 筋障害診断方法

Country Status (4)

Country Link
US (1) US7611902B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029771A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009540314A (cg-RX-API-DMAC7.html)
WO (1) WO2007144467A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
EP3502707A1 (en) * 2010-01-29 2019-06-26 metanomics GmbH Means and methods for diagnosing heart failure in a subject
US8778618B2 (en) * 2010-04-16 2014-07-15 The Johns Hopkins University Compositions and methods for characterizing a myopathy
NO2385374T3 (cg-RX-API-DMAC7.html) 2010-05-05 2014-06-07
AU2011260390B2 (en) * 2010-06-01 2016-11-24 Ernst-Moritz-Arndt Universitat Greifswald Means and methods for diagnosing pancreatic cancer in a subject
EP2583107A2 (en) * 2010-06-20 2013-04-24 Zora Biosciences OY Lipidomic biomarkers for identification of high-risk coronary artery disease patients
US9541565B2 (en) 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
EP2977764A1 (en) * 2011-04-08 2016-01-27 Zora Biosciences OY Biomarkers for sensitive detection of statin-induced muscle toxicity
US9664698B2 (en) * 2011-04-08 2017-05-30 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
JP2016191718A (ja) * 2016-07-27 2016-11-10 ゾラ バイオサイエンシーズ オサケ ユキチュア スタチン誘発性筋毒性の高感度検出のためのバイオマーカー
RU2641038C1 (ru) * 2017-03-06 2018-01-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Способ диагностики врожденной миопатии центрального стержня

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60225145D1 (de) * 2001-07-06 2008-04-03 Lipomics Technologies Inc Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
DK1438420T3 (da) * 2001-09-24 2010-01-18 Lipomics Technologies Inc Fremgangsmåder til anvendelse af kvantitative lipid-metablom-data
EP1465667A4 (en) * 2001-09-24 2007-06-27 Merck & Co Inc SCREENING AND SELECTION PROCEDURE FOR STATIN COMBINATIONS
WO2003079026A1 (en) * 2002-03-12 2003-09-25 Phillips Paul S Method of diagnosing statin myopathy
WO2004055174A1 (fr) * 2002-12-13 2004-07-01 Celogos Composition de milieu de culture, procede de culture, et myoblastes ainsi obtenus, et leurs utilisations
US20050037946A1 (en) * 2003-01-13 2005-02-17 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
US20070202518A1 (en) * 2005-11-18 2007-08-30 Genomas, Inc. Physiogenomic method for predicting statin injury to muscle and muscle side effects
WO2007061995A2 (en) * 2005-11-21 2007-05-31 Novartis Ag Biomarkers for statin-induced myopathy or rhabdomyolysis

Similar Documents

Publication Publication Date Title
JP2009540314A5 (cg-RX-API-DMAC7.html)
JP2009538607A5 (cg-RX-API-DMAC7.html)
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
EP2319941A3 (en) Method and apparatus for correlating levels of biomarker products with disease
EP1662993A4 (en) BIOIMPEDANCE METHOD AND DEVICE
WO2007056560A3 (en) System and method for cytological analysis by raman spectroscopic imaging
EP2222355A4 (en) INTRADUCTAL DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR THE MEIBOMINE AND RELEVANT DEVICE
NO20070592L (no) Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.
FR2872659B1 (fr) Procede et appareil pour une reconstruction directe en imagerie par tomosynthese
JP2010506147A5 (cg-RX-API-DMAC7.html)
EP2532748A3 (en) DNA aptamer specifically binding to human cardiac troponin I
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
WO2008154570A3 (en) Method for stimulating saliva production during oral sample collection procedure
DE502004005226D1 (de) Diagnosestellung von akuten myokardialen, ischämischen erkrankungen durch kombination von markern
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
WO2008017984A3 (en) A method, apparatus, graphical user interface, computer-readable medium, and use for quantification of a structure in an object of an image dataset
JP2012189581A5 (cg-RX-API-DMAC7.html)
WO2003069553A3 (en) Method of image analysis
EP1929258A4 (en) PHOTOELECTRONIC SPECTROSCOPY DEVICE AND USE METHOD
JP2013526863A5 (cg-RX-API-DMAC7.html)
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease
EP2527358A3 (en) Diagnostic assay
CN110320184A (zh) 基于对皮肤和指甲角蛋白的检测判断帕金森病的方法及其应用
ITRM20040098A1 (it) Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression